A comparison of the third-generation aromatase inhibitors and their effects on postmenopausal women with early hormone sensitive breast cancer
Breast cancer is the most common malignancy and the second highest cause of cancer death in women. Many of these tumours are oestrogen dependent and can be treated using compounds which are themselves antioestrogenic or reduce the production of oestrogen. Until recently, the selective oestrogen rece...
| Main Author: | |
|---|---|
| Published: |
University of Edinburgh
2012
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.726465 |